Search
Search Results
##search.searchResults.foundPlural##
-
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2436PDF: 1598HTML: 646 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2921PDF: 1371HTML: 3578Untitled: 195Untitled: 211Untitled: 184 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1314PDF: 912HTML: 1281fig 1A: 176figure1B: 152 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4451PDF: 1648HTML: 4050Tables and Images: 232 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2318PDF: 1340HTML: 17093Bassan Fig.1: 146Bassan Fig.2: 159Bassan Fig.4: 142Fig.3: 196 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2253PDF: 950HTML: 6794Figure 1: 175 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3743PDF: 1468HTML: 188 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2293PDF: 1638HTML: 275 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2600PDF: 879HTML: 2125 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2836PDF: 1017HTML: 5526 -
-
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1278PDF: 1484Suppl. Files: 150HTML: 80 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4090PDF: 1158HTML: 1962Fig.1: 219Fig. 2: 113Table 1: 204Table2: 223Table 3: 203 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2149PDF: 1332HTML: 3505 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2091PDF: 1904HTML: 350 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1051PDF: 943Suppl. Files: 596HTML: 89 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7657PDF: 2442HTML: 1740Table 1.: 214Table 2.: 224Table 3.: 208Table 4.: 209 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3656PDF: 903HTML: 6721 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1381PDF: 848HTML: 10067cover letter to the editor: 169tile page: 252 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4002Suppl. Files: 1140PDF: 1086Html: 180 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1702PDF: 819HTML: 938cover letter: 274 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1264PDF: 1015HTML: 224 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1658PDF: 1247HTML: 265 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3434PDF: 1042HTML: 1009Figure 1: 176 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2804PDF: 1026HTML: 422TABLE: 195FIGURES: 259 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1311PDF: 608HTML: 3104 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2796PDF: 1132HTML: 3294 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4299PDF: 3540HTML: 220







